ATNM — ACTINIUM PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $35.2M | +2306.3% | $5.5M | — | 22.5% | — | 79.7% | — | — | — | — |
Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.28 | — | -0.24 | -0.32 | 2 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 0.19 | 7.0× | 0.25 | 0.12 | 2 | — |
| Dec 2027 | -0.69 | — | -0.65 | -0.72 | 2 | — |
| Dec 2028 | -0.69 | — | -0.62 | -0.75 | 2 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 51 SEC-registered investment managers reported holding ATNM (ACTINIUM PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $5.66M across 5.06M shares. That is -7.0% by share count (-359.64K shares) versus the previous quarter, while reported value moved +6.3%. Ownership is concentrated: the five largest holders account for 59.0% of reported value and the top ten for 84.4%.
Compared with the prior quarter, 9 opened new positions, 4 added to existing stakes, 19 trimmed, 8 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ACTINIUM PHARMACEUTICALS INC (ATNM) include Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Hudson Bay Capital Management LP, ranked by reported 13F value among the 164 institutional holders on this page.
ATNM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 51 | 5.06M | $5.66M | -6.9% |
| Q2 2026 | 49 | 5.54M | $5.43M | -7.3% |
| Q1 2026 | 56 | 5.38M | $5.35M | +8.4% |
| Q4 2025 | 61 | 5.39M | $7.33M | +1.6% |
| Q3 2025 | 61 | 5.11M | $8.18M | -10.3% |
| Q2 2025 | 62 | 5.68M | $7.95M | -43.3% |
| Q1 2025 | 72 | 7.79M | $12.52M | +2.4% |
| Q4 2024 | 71 | 7.68M | $9.67M | -3.1% |
Over the 8 quarters shown, institutional share counts decreased 34% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (-43.3%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.23M | $1.38M | 0.00% | Hold | |
| 483.67K | $541.71K | 0.00% | Reduce | |
| 483.67K | $541.71K | 0.00% | Reduce | |
| 390.97K | $437.89K | 0.00% | Reduce | |
| 389.23K | $435.94K | 0.05% | Reduce | |
| 342.59K | $383.70K | 0.00% | Reduce | |
| 324.94K | $364.06K | 0.00% | Hold | |
| 234.86K | $263.04K | 0.00% | Reduce | |
| 200.59K | $224.66K | 0.00% | Add | |
| 182.14K | $204.00K | 0.04% | Hold | |
| 122.22K | $136.88K | 0.00% | Reduce | |
| 92.86K | $104.00K | 0.02% | Add | |
| 69.74K | $78.11K | 0.00% | Hold | |
| 59.83K | $67.00K | 0.02% | Reduce | |
| 50.00K | $56.00K | 0.00% | Hold | |
| 50.00K | $56.00K | 0.00% | Add | |
| 41.09K | $46.02K | 0.00% | New | |
| 39.35K | $44.08K | 0.00% | New | |
| 39.35K | $44.08K | 0.00% | Reduce | |
| 31.73K | $35.54K | 0.00% | Reduce | |
| 22.00K | $24.64K | 0.00% | Hold | |
| 19.92K | $22.31K | 0.01% | Reduce | |
| 18.74K | $20.99K | 0.00% | Reduce | |
| 16.80K | $18.82K | 0.00% | Add | |
| 16.55K | $18.00K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.24M | $1.21M | 0.00% | Reduce | |
| 600.23K | $588.23K | 0.09% | New | |
| 514.58K | $504.29K | 0.00% | Reduce | |
| 514.58K | $504.29K | 0.00% | Reduce | |
| 395.90K | $387.98K | 0.00% | Add | |
| 380.49K | $372.88K | 0.00% | Reduce | |
| 324.94K | $318.55K | 0.00% | New | |
| 324.94K | $318.55K | 0.00% | Reduce | |
| 259.18K | $254.00K | 0.00% | Reduce | |
| 182.14K | $178.50K | 0.03% | Reduce | |
| 161.53K | $158.29K | 0.00% | Add | |
| 105.11K | $103.01K | 0.03% | Reduce | |
| 69.74K | $68.35K | 0.00% | Reduce | |
| 57.81K | $56.66K | 0.00% | Add | |
| 56.82K | $55.69K | 0.00% | Reduce | |
| 50.00K | $49.00K | 0.00% | Add | |
| 43.00K | $42.14K | 0.00% | New | |
| 40.00K | $39.20K | 0.00% | Hold | |
| 29.36K | $29.00K | 0.01% | Hold | |
| 22.69K | $22.24K | 0.01% | Hold | |
| 22.00K | $21.56K | 0.00% | Hold | |
| 20.00K | $19.60K | 0.00% | Hold | |
| 19.80K | $19.40K | 0.00% | Hold | |
| 19.50K | $19.11K | 0.00% | Reduce | |
| 18.86K | $18.49K | 0.00% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.26M | $1.25M | 0.00% | New | |
| 564.60K | $561.95K | 0.00% | Reduce | |
| 564.60K | $561.95K | 0.00% | Reduce | |
| 471.60K | $469.38K | 0.00% | Add | |
| 371.21K | $369.47K | 0.00% | Add | |
| 337.17K | $335.58K | 0.00% | Add | |
| 336.07K | $334.59K | 0.00% | Add | |
| 201.30K | $200.35K | 0.05% | Hold | |
| 160.26K | $159.46K | 0.00% | New | |
| 126.22K | $125.62K | 0.00% | Hold | |
| 124.00K | $123.42K | 0.00% | Add | |
| 107.11K | $106.61K | 0.03% | Hold | |
| 101.10K | $100.62K | 0.00% | Reduce | |
| 75.86K | $75.50K | 0.00% | Add | |
| 70.24K | $69.91K | 0.00% | Hold | |
| 40.00K | $39.81K | 0.00% | Hold | |
| 35.89K | $35.72K | 0.00% | Add | |
| 35.23K | $35.06K | 0.01% | Add | |
| 34.92K | $34.76K | 0.00% | Hold | |
| 30.21K | $30.07K | 0.00% | Add | |
| 30.00K | $29.86K | 0.00% | Hold | |
| 29.36K | $29.00K | 0.01% | Hold | |
| 26.40K | $26.28K | 0.00% | Reduce | |
| 22.69K | $22.58K | 0.01% | New | |
| 22.00K | $21.90K | 0.00% | Hold |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.42M | $1.93M | 0.00% | Add | |
| 601.60K | $818.18K | 0.00% | Reduce | |
| 601.60K | $818.18K | 0.00% | Reduce | |
| 390.78K | $531.47K | 0.00% | Add | |
| 366.93K | $499.03K | 0.00% | Add | |
| 328.99K | $447.56K | 0.00% | Hold | |
| 209.69K | $285.18K | 0.00% | Reduce | |
| 201.81K | $274.46K | 0.06% | Reduce | |
| 196.08K | $266.66K | 0.00% | Hold | |
| 126.22K | $171.65K | 0.00% | Hold | |
| 114.70K | $155.99K | 0.00% | Add | |
| 107.13K | $145.70K | 0.05% | Reduce | |
| 70.36K | $95.69K | 0.00% | New | |
| 65.73K | $89.39K | 0.00% | New | |
| 57.87K | $78.70K | 0.00% | New | |
| 42.61K | $57.95K | 0.00% | Add | |
| 40.00K | $54.40K | 0.00% | Hold | |
| 34.92K | $47.49K | 0.00% | Hold | |
| 30.00K | $40.80K | 0.00% | Hold | |
| 29.70K | $40.39K | 0.00% | Reduce | |
| 29.36K | $40.00K | 0.01% | New | |
| 25.98K | $35.33K | 0.00% | Add | |
| 23.60K | $32.10K | 0.00% | Hold | |
| 22.00K | $29.92K | 0.01% | Hold | |
| 20.27K | $27.56K | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.38M | $2.22M | 0.00% | Add | |
| 624.70K | $999.51K | 0.00% | Reduce | |
| 624.70K | $999.51K | 0.00% | Reduce | |
| 363.49K | $581.58K | 0.00% | Reduce | |
| 328.42K | $525.63K | 0.00% | Hold | |
| 288.63K | $461.81K | 0.00% | Add | |
| 234.29K | $374.87K | 0.00% | Add | |
| 226.26K | $362.01K | 0.07% | Hold | |
| 196.38K | $314.20K | 0.00% | New | |
| 126.22K | $201.94K | 0.00% | Reduce | |
| 109.38K | $175.01K | 0.06% | New | |
| 93.02K | $148.84K | 0.00% | Reduce | |
| 40.00K | $64.00K | 0.00% | Hold | |
| 35.90K | $57.43K | 0.00% | Reduce | |
| 34.92K | $55.88K | 0.00% | Hold | |
| 30.00K | $48.00K | 0.00% | Hold | |
| 26.34K | $42.14K | 0.00% | Reduce | |
| 25.72K | $41.16K | 0.00% | Reduce | |
| 25.10K | $40.16K | 0.00% | Reduce | |
| 23.60K | $37.77K | 0.00% | Hold | |
| 22.00K | $35.20K | 0.01% | New | |
| 21.10K | $33.76K | 0.00% | Reduce | |
| 20.00K | $32.00K | 0.00% | Hold | |
| 19.96K | $31.94K | 0.00% | Add | |
| 19.80K | $31.68K | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.37M | $1.92M | 0.00% | Reduce | |
| 663.27K | $928.58K | 0.00% | New | |
| 663.27K | $928.58K | 0.00% | New | |
| 467.67K | $654.74K | 0.00% | Reduce | |
| 329.69K | $461.70K | 0.00% | Reduce | |
| 226.62K | $317.27K | 0.06% | Hold | |
| 222.01K | $310.82K | 0.00% | Reduce | |
| 218.32K | $305.65K | 0.00% | New | |
| 209.50K | $293.30K | 0.00% | Add | |
| 109.38K | $153.13K | 0.01% | Add | |
| 98.12K | $137.37K | 0.00% | New | |
| 91.41K | $127.97K | 0.00% | Add | |
| 83.07K | $116.30K | 0.00% | Add | |
| 77.22K | $108.11K | 0.00% | Add | |
| 77.22K | $108.11K | 0.00% | Add | |
| 64.91K | $90.87K | 0.00% | New | |
| 59.99K | $83.99K | 0.00% | Reduce | |
| 49.93K | $69.91K | 0.00% | New | |
| 46.55K | $65.16K | 0.00% | New | |
| 44.70K | $62.58K | 0.00% | Reduce | |
| 40.00K | $56.00K | 0.00% | Reduce | |
| 39.20K | $54.88K | 0.00% | Add | |
| 34.92K | $48.89K | 0.00% | Hold | |
| 30.90K | $43.26K | 0.00% | New | |
| 30.87K | $43.00K | 0.01% | Hold |
New Positions (Q3 2026)
- Keel Point, LLC 41.09K sh · $46.02K
- Empowered Funds, LLC 39.35K sh · $44.08K
- HRT FINANCIAL LP 16.55K sh · $18.00K
- Citadel Advisors 13.92K sh · $15.59K
- Prudential Financial 13.40K sh · $15.01K
- Citigroup Inc 8.79K sh · $9.84K
- Fidelity Management & Research (FMR) 1.33K sh · $1.49K
- Tower Research Capital LLC (TRC) 336 sh · $376
- Cassaday & Co Wealth Management LLC 16 sh · $18
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 324.94K sh · $318.55K
- NORTH STAR ASSET MANAGEMENT INC sold 20.00K sh · $19.60K
- JANE STREET GROUP, LLC sold 19.50K sh · $19.11K
- XTX Topco Ltd sold 13.73K sh · $13.46K
- NISA INVESTMENT ADVISORS, LLC sold 330 sh · $323
- Allied Private Wealth LLC sold 240 sh · $232
- FEDERATED HERMES, INC. sold 137 sh · $134
- Axiom Investment Management LLC sold 5 sh · $5
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.23M | 1.24M | 1.26M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | 483.67K | 514.58K | 564.60K | 601.60K | 624.70K | 663.27K | — | 117.45K | 160.12K | 21.04K | 67.41K | — | — | — | — | — | — | — | — | — |
| Millennium Management | 483.67K | 514.58K | 564.60K | 601.60K | 624.70K | 663.27K | — | 117.45K | 160.12K | 21.04K | 67.41K | — | — | — | 231.17K | 53.78K | 49.15K | 33.14K | — | — |
| BlackRock Inc | 390.97K | 395.90K | 371.21K | 366.93K | 363.49K | 467.67K | 1.95M | 1.97M | 1.94M | — | — | — | — | — | — | — | — | — | — | — |
| COMPASS FINANCIAL MANAGEMENT LLC | 389.23K | 600.23K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 342.59K | 380.49K | 471.60K | 390.78K | 288.63K | 209.50K | 57.60K | 190.40K | 127.00K | 19.20K | — | — | — | 48.30K | 102.20K | 159.60K | 78.30K | 57.70K | — | — |
| Geode Capital Management | 324.94K | 324.94K | 336.07K | 328.99K | 328.42K | 329.69K | 711.80K | 687.85K | 686.15K | 666.31K | 595.72K | 569.55K | 542.44K | 521.38K | 232.43K | 231.69K | 214.17K | 172.22K | 167.17K | 167.17K |
| Two Sigma Investments | 234.86K | 259.18K | 337.17K | 209.69K | 234.29K | 46.55K | — | — | — | — | — | — | — | 19.47K | 45.54K | 213.32K | 15.83K | 57.22K | — | — |
| VANGUARD FIDUCIARY TRUST CO | 200.59K | 161.53K | 160.26K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GAGNON SECURITIES LLC | 182.14K | 182.14K | 201.30K | 201.81K | 226.26K | 226.62K | 226.62K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 122.22K | — | 126.22K | 126.22K | 126.22K | 222.01K | 645.22K | 621.08K | 602.65K | 609.67K | 550.85K | 506.84K | 522.99K | — | — | — | — | — | — | — |
| AM INVESTMENT STRATEGIES LLC | 92.86K | 29.36K | 29.36K | 29.36K | — | 30.87K | 30.87K | 14.42K | 14.42K | 13.58K | 12.58K | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 69.74K | 69.74K | 75.86K | 42.61K | 35.90K | 59.99K | 228.27K | 251.93K | 240.12K | 228.46K | 230.60K | 226.39K | 220.38K | 219.34K | 44.56K | 44.78K | 39.23K | 38.05K | 37.37K | 37.99K |
| Gen-Wealth Partners Inc | 59.83K | 105.11K | 107.11K | 107.13K | 109.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vontobel Holding Ltd. | 50.00K | 50.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 25.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| Bluespring Wealth Management, LLC | 50.00K | 43.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Keel Point, LLC | 41.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 39.35K | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | 75.00K | 75.70K | 77.00K | 83.97K | 83.97K | 83.97K | 63.97K | — | — | — | — | — | — | — |
| Empowered Funds, LLC | 39.35K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31.73K | 56.82K | 124.00K | 13.10K | 17.20K | 83.07K | 10.70K | 14.40K | 22.49K | 39.50K | 53.90K | 33.50K | 30.50K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ATNM?
As of 2026-Q3, 51 institutional funds reported holding ATNM (ACTINIUM PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $5.66M.
How many shares of ATNM do institutions own?
13F filers reported 5.06M shares of ATNM, worth $5.66M in aggregate at the end of 2026-Q3.
Is institutional ownership of ATNM rising or falling?
Share counts moved -7.0% versus the prior quarter — distribution.
Who are the top institutional holders of ATNM?
The largest 13F holders are Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Hudson Bay Capital Management LP, BIT Capital GmbH, ADAR1 Capital Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ACTINIUM PHARMACEUTICALS INC?
The major shareholders of ACTINIUM PHARMACEUTICALS INC (ATNM) by reported 13F value are Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Hudson Bay Capital Management LP, BIT Capital GmbH, ADAR1 Capital Management, LLC, among 164 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.